However, under unique conditions where a single epitope drove intrathecal inflammation (i.e. in an altered peptide ligand trial in MS), the precursor frequency of MBP83-99-specific CD4+ T cells was equal to or higher than 1/1000 in the blood and 1/100 in the CSF [36]. This evidence concerns the gene CD4 and myeloid sarcoma.